☰

Georgialina Rodriguez, Ph.D. - Publications

Affiliations: 
2008 The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Sun S, Rodriguez G, Zhao G, Sanchez JE, Guo W, Du D, Rodriguez Moncivais OJ, Hu D, Liu J, Kirken RA, Li L. A novel approach to study multi-domain motions in JAK1's activation mechanism based on energy landscape. Briefings in Bioinformatics. 25. PMID 38446738 DOI: 10.1093/bib/bbae079  0.613
2023 Rodriguez Moncivais OJ, Chavez SA, Estrada Jimenez VH, Sun S, Li L, Kirken RA, Rodriguez G. Structural Analysis of Janus Tyrosine Kinase Variants in Hematological Malignancies: Implications for Drug Development and Opportunities for Novel Therapeutic Strategies. International Journal of Molecular Sciences. 24. PMID 37834019 DOI: 10.3390/ijms241914573  0.595
2023 Rodriguez G, Martinez GS, Negrete OD, Sun S, Guo W, Xie Y, Li L, Xiao C, Ross JA, Kirken RA. JAK3 Y841 Autophosphorylation Is Critical for STAT5B Activation, Kinase Domain Stability and Dimer Formation. International Journal of Molecular Sciences. 24. PMID 37569303 DOI: 10.3390/ijms241511928  0.61
2023 Sun S, Rodriguez G, Xie Y, Guo W, Hernandez AEL, Sanchez JE, Kirken RA, Li L. Phosphorylation of Tyrosine 841 Plays a Significant Role in JAK3 Activation. Life (Basel, Switzerland). 13. PMID 37109511 DOI: 10.3390/life13040981  0.611
2023 Grant AH, Rodriguez AC, Rodriguez Moncivais OJ, Sun S, Li L, Mohl JE, Leung MY, Kirken RA, Rodriguez G. JAK1 Pseudokinase V666G Mutant Dominantly Impairs JAK3 Phosphorylation and IL-2 Signaling. International Journal of Molecular Sciences. 24. PMID 37047778 DOI: 10.3390/ijms24076805  0.637
2023 Robles-Escajeda E, Mohl JE, Contreras L, Betancourt AP, Mancera BM, Kirken RA, Rodriguez G. Rapid Shift from SARS-CoV-2 Delta to Omicron Sub-Variants within a Dynamic Southern U.S. Borderplex. Viruses. 15. PMID 36992367 DOI: 10.3390/v15030658  0.51
2021 Ayala-Marin YM, Grant AH, Rodriguez G, Kirken RA. Quadruple and Truncated MEK3 Mutants Identified from Acute Lymphoblastic Leukemia Promote Degradation and Enhance Proliferation. International Journal of Molecular Sciences. 22. PMID 34830095 DOI: 10.3390/ijms222212210  0.641
2021 Estrada A, Rodriguez AC, Rodriguez G, Grant AH, Ayala-Marin YM, Arrieta AJ, Kirken RA. Phosphorylation of CrkL S114 induced by common gamma chain cytokines and T-cell receptor signal transduction. Scientific Reports. 11: 16951. PMID 34417497 DOI: 10.1038/s41598-021-96428-y  0.62
2021 Grant AH, Estrada A, Ayala-Marin YM, Alvidrez-Camacho AY, Rodriguez G, Robles-Escajeda E, Cadena-Medina DA, Rodriguez AC, Kirken RA. The Many Faces of JAKs and STATs Within the COVID-19 Storm. Frontiers in Immunology. 12: 690477. PMID 34326843 DOI: 10.3389/fimmu.2021.690477  0.587
2021 Grant AH, Ayala-Marin YM, Mohl JE, Robles-Escajeda E, Rodriguez G, Dutil J, Kirken RA. The Genomic Landscape of a Restricted ALL Cohort from Patients Residing on the U.S./Mexico Border. International Journal of Environmental Research and Public Health. 18. PMID 34299796 DOI: 10.3390/ijerph18147345  0.552
2020 Valenzuela P, Oaxaca D, Di Desidero T, Parra K, Rodriguez G, Manciu M, Allegrini G, Falcone A, Bocci G, Kirken RA, Francia G. Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients. Clinical and Experimental Medicine. PMID 33048259 DOI: 10.1007/s10238-020-00666-9  0.574
2017 Parra K, Valenzuela P, Lerma N, Gallegos A, Reza LC, Rodriguez G, Emmenegger U, Di Desidero T, Bocci G, Felder MS, Manciu M, Kirken RA, Francia G. Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth. British Journal of Cancer. PMID 28056464 DOI: 10.1038/Bjc.2016.429  0.584
2017 Valenzuela P, Parra K, Oaxaca D, Reza L, Lopez J, Arreguin MG, Garcia D, Rodriguez G, Falcone A, Allegrini G, Desidero TD, Bocci G, Kirken R, Francia G. Abstract 784: Pharmacodynamic biomarkers in metronomic chemotherapy: Multiplex cytokine measurements in gastrointestinal cancer patients Cancer Research. 77: 784-784. DOI: 10.1158/1538-7445.Am2017-784  0.581
2016 Oaxaca DM, Yang-Reid SA, Ross JA, Rodriguez G, Staniswalis JG, Kirken RA. Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 27444277 DOI: 10.1007/S13277-016-5179-7  0.58
2016 Parra K, Valenzuela P, Gallegos AE, Lerma N, Reza L, Rodriguez G, Emmenegger U, Manciu M, Desidero TD, Bocci G, Felder MS, Kirken RA, Francia G. Abstract 3261: Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth Cancer Research. 76: 3261-3261. DOI: 10.1158/1538-7445.Am2016-3261  0.565
2014 Parra K, Vidal C, Valenzuela P, Jallad S, Rodriguez G, Felder MS, Lerma N, Bocci G, Emmenegger U, Kirken RA, Francia G. Abstract 2987: Evaluation of CTLA-4 blockage with sequential metronomic chemotherapy for the treatment of preclinical breast cancer Cancer Research. 74: 2987-2987. DOI: 10.1158/1538-7445.Am2014-2987  0.567
2013 Nagy ZS, Ross JA, Rodriguez G, Balint BL, Szeles L, Nagy L, Kirken RA. Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells. Plos One. 8: e57326. PMID 23451206 DOI: 10.1371/Journal.Pone.0057326  0.65
2013 Rodriguez G, Ross JA, Nagy ZS, Kirken RA. Forskolin-inducible cAMP pathway negatively regulates T-cell proliferation by uncoupling the interleukin-2 receptor complex. The Journal of Biological Chemistry. 288: 7137-46. PMID 23341462 DOI: 10.1074/Jbc.M112.408765  0.662
2013 Ross JA, Rodriguez G, Kirken RA. Analysis of Janus tyrosine kinase phosphorylation and activation. Methods in Molecular Biology (Clifton, N.J.). 967: 3-20. PMID 23296718 DOI: 10.1007/978-1-62703-242-1_1  0.648
2013 Nagy ZS, Ross JA, Rodriguez G, Balint BL, Szeles L, Nagy L, Kirken RA. Correction: Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells (PLoS ONE) Plos One. 8. DOI: 10.1371/annotation/cb55d096-61f8-46de-b58f-81a872be6dd3  0.594
2012 Mitra A, Ross JA, Rodriguez G, Nagy ZS, Wilson HL, Kirken RA. Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary hematopoietic malignancies. The Journal of Biological Chemistry. 287: 16596-608. PMID 22442148 DOI: 10.1074/Jbc.M111.319756  0.683
2010 Nagy ZS, Ross JA, Rodriguez G, Bader J, Dimmock J, Kirken RA. Uncoupling JAK3 activation induces apoptosis in human lymphoid cancer cells via regulating critical survival pathways. Febs Letters. 584: 1515-20. PMID 20211620 DOI: 10.1016/J.Febslet.2010.02.071  0.661
Show low-probability matches.